Citius Pharmaceuticals, Inc (CTXR) Stock Price

0.712 ▼ -0.0594 (-7.70%)
Open: 0.8125 Vol: 1.72M Day's range: 0.712 - 0.85 Feb 05, 16:00 EST
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
CTXR Technical Analysis
5 mins 30 mins Hourly Daily Weekly
SELL SELL SELL SELL SELL
  5 mins 30 mins Hourly Daily Weekly
MA5 0.73▼ 0.74▼ 0.74▼ 0.75▼ 0.81▼
MA10 0.74▼ 0.75▼ 0.75▼ 0.78▼ 0.91▼
MA20 0.75▼ 0.76▼ 0.76▼ 0.82▼ 1.13▼
MA50 0.76▼ 0.76▼ 0.77▼ 0.97▼ 1.19▼
MA100 0.76▼ 0.79▼ 0.80▼ 1.14▼ 6.68▼
MA200 0.79▼ 0.82▼ 0.85▼ 1.16▼ 16.17▼
  5 mins 30 mins Hourly Daily Weekly
MACD -0.003▼ -0.004▼ -0.003▼ 0.000▲ 0.000▼
RSI 39.469▼ 40.985▼ 40.497▼ 33.273▼ 36.960▼
STOCH 12.257▼ 15.795▼ 14.561▼ 22.116     21.199    
WILL %R -100.000▼ -100.000▼ -100.000▼ -100.000▼ -91.546▼
CCI -146.123▼ -119.686▼ -137.166▼ -92.226     -93.010    
Latest Filters Detected On CTXR
▲ GAP $CTXR Open Gap Up %5 Set Alert
▲ GAP $CTXR Open Gap Up %3 Set Alert
▲ GAP $CTXR Open Gap Up %2 Set Alert
▼ BREAK $CTXR Price Breaks 20 Days Low Set Alert
▼ BREAK $CTXR Price Breaks 10 Days Low Set Alert
Citius Pharmaceuticals, Inc News
Citius Pharmaceuticals (CTXR) Surges 22% After Hours — Here's Why
Tuesday, December 23, 2025 05:56 PM
Citius Pharmaceuticals Inc. (NASDAQ: CTXR) shares jumped 22.12% in after-hours trading to $1.27 on Tuesday, following the company’s fiscal year 2025 business update and the commercial launch of its ...
Citius Oncology Announces $18 Million Concurrent Registered Direct Offering and Private Placement Priced At-The-Market Under Nasdaq Rules
Tuesday, December 09, 2025 05:31 AM
CRANFORD, N.J., Dec. 9, 2025 /PRNewswire/ -- Citius Oncology, Inc. ("Citius Oncology" or the "Company") (Nasdaq: CTOR), the oncology-focused subsidiary of Citius ...
Citius Oncology Announces $18 Million Concurrent Registered Direct Offering and Private Placement Priced At-The-Market Under Nasdaq Rules
Monday, December 08, 2025 09:30 PM
Proceeds strengthen cash position and support commercial launch of LYMPHIR™, a novel cancer immunotherapy for cutaneous T-cell lymphoma (CTCL) CRANFORD, N.J., Dec. 9, 2025 /PRNewswire/ -- Citius ...
CTXR historical stock data
date open high low close volume
05/02/26 0.8125 0.85 0.712 0.712 1,715,293
04/02/26 0.80 0.80 0.7446 0.7714 196,776
03/02/26 0.7765 0.80 0.7406 0.7832 542,821
02/02/26 0.7409 0.7682 0.7286 0.7597 404,474
30/01/26 0.7528 0.78 0.7388 0.7401 265,237
29/01/26 0.80 0.80 0.75 0.77 386,426
28/01/26 0.8074 0.8394 0.78 0.7801 252,509
27/01/26 0.81 0.8323 0.7901 0.8276 275,977
26/01/26 0.8345 0.849 0.8113 0.8265 137,118
23/01/26 0.821 0.85 0.8059 0.85 182,791
Quote Details
52wk Low:0.63
52wk High:2.97
Vol:1.72M
Avg Vol(3m):13.7M
1Y Chng:-58.36%
1M Chng:-31.54%
Add to Watch List
More Information
Index US Composite
Market Cap. 17.26M